The frequency of clinically relevant transmitted drug resistance mutations (DRMs) against drugs used for 2-drug regimens was 15.6%, but only 2% were not eligible for 1 or more 2-drug regimens. More than 50% of patients harboring any clinically relevant DRMs were found to be part of genetic transmission clusters.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942491 | PMC |
| http://dx.doi.org/10.1093/ofid/ofz535 | DOI Listing |
Publication Analysis
Top Keywords
2-drug regimens
12
transmitted drug
8
drug resistance
8
resistance mutations
8
clinically relevant
8
antiretroviral treatment
4
treatment simplification
4
simplification 2-drug
4
regimens impact
4
impact transmitted
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!